Longitudinal analysis of UK Biobank participants suggests age and APOE-dependent alterations of energy metabolism in development of dementia
Liu, J.; Amin, N.; Sproviero, W.; Arnold, M.; Batra, R.; Bonnechere, B.; Chiou, Y.-J.; Fernandes, M.; Krumsiek, J.; Newby, D.; Nho, K.; Kim, J. P.; Saykin, A. J.; Shi, L.; Winchester, L.; Yang, Y.; Nevado-Holgado, A. J.; Kastenmuller, G.; Kaddurah-Daouk, R.; van Duijn, C.
Show abstract
Experimental models shows that bioenergetic homeostasis changes with increasing age based on apolipoprotein E (APOE) gene. However, such link with dementia remains unclear in population. We used H1-NMR metabolome in blood from 118,021 random-selected participants in UK Biobank (n=118,021 individuals), and identified 56 metabolites associated with the risk of dementia. In the participants without developing dementia during follow-up, 82% (46/56) metabolites are also associated with reaction time, and dementia shares metabolite signatures with total brain volume. We found that incident Alzheimers disease (AD) is associated with energy metabolism-related metabolites, i.e, {beta}-hydroxybutyrate, acetone, and valine, whose concentrations in blood are influenced by age and APOE genotype. Valine shows a declined trajectories after a plateau at age around 60 years which is in parallel with body mass index. Moreover, we found associations of AD with valine and {beta}-hydroxybutyrate in brain tissue are different as their associations in the periphery, which implies the key role of transports in regulating the energy metabolism of AD. Our study provides strong evidence in population level that the onset of AD in APOE4 carriers is regulated by the impaired energy balance in the brain.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Individual bioenergetic capacity as a potential source of resilience to Alzheimer’s disease 97%
- Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology 96%
- Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer 96%
Similar papers in this journal
- Adherence to Life’s Essential 8 is associated with delayed white matter aging 94%
- The ratio of plasma pTau181 and pTau217 to Aβ42 outperforms individual measurements in detecting brain amyloidosis 94%
- Prediction of brain age using structural magnetic resonance imaging: A comparison of clinical validity of publicly available software packages 93%
Similar papers in this journal
- Identification of a specific APOE transcript and functional elements associated with Alzheimer's disease 95%
- APOE4 Lowers Energy Expenditure and Impairs Glucose Oxidation by Increasing Flux through Aerobic Glycolysis 94%
- A Microglial Activity State Biomarker Panel Differentiates Ftd-Granulin And Ad From Control Cases 94%